PROCEPT BioRobotics (PRCT) Fundamental Analysis: Revenue, Earnings & Valuation

0.93 / 10

Underperform

Fundamental rating is Underperform with a 0.9/10 score. Profit‑MV and Revenue‑MV are modestly positive, but Cash‑MV, ROA, and profit margins are negative, indicating constrained profitability and cash generation.

Analysis Checks(2/10)

Revenue-MV

Value-1.09

Score2/3

Weight-14.75%

1M Return1.21%

ROA (%)

Value-18.34

Score1/3

Weight9.69%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-15.90

Score1/3

Weight15.27%

1M Return-1.35%

Profit-MV

Value0.66

Score2/3

Weight-43.90%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-18.34

Score1/3

Weight9.69%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-33.77

Score1/3

Weight8.64%

1M Return-0.83%

Asset-MV

Value-0.55

Score0/3

Weight38.19%

1M Return-3.44%

Net profit / Total operating revenue (%)

Value-31.02

Score1/3

Weight9.87%

1M Return-0.84%

Cash-MV

Value0.02

Score1/3

Weight41.61%

1M Return-4.16%

Net profit / Total profit (%)

Value100.20

Score1/3

Weight25.70%

1M Return-2.39%

Is PRCT fundamentally strong?

PRCT scores 0.93/10 on fundamentals and holds a Premium valuation at present. Backed by its -24.89% ROE, -31.02% net margin, -14.96 P/E ratio, 3.91 P/B ratio, and 1.71% earnings growth, these metrics solidify its Underperform investment rating.